Next Article in Journal
Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach
Next Article in Special Issue
The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease—A Systematic Literature Review
Previous Article in Journal
Surface-Functionalized NdVO4:Gd3+ Nanoplates as Active Agents for Near-Infrared-Light-Triggered and Multimodal-Imaging-Guided Photothermal Therapy
Previous Article in Special Issue
Application of a Physiologically Based Pharmacokinetic Model to Predict Cefazolin and Cefuroxime Disposition in Obese Pregnant Women Undergoing Caesarean Section
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(6), 1220; https://doi.org/10.3390/pharmaceutics14061220
Action Date Notes Link
article xml file uploaded 8 June 2022 12:10 CEST Original file -
article xml uploaded. 8 June 2022 12:10 CEST Update https://www.mdpi.com/1999-4923/14/6/1220/xml
article pdf uploaded. 8 June 2022 12:10 CEST Version of Record https://www.mdpi.com/1999-4923/14/6/1220/pdf
article html file updated 8 June 2022 12:11 CEST Original file -
article html file updated 3 August 2022 04:03 CEST Update https://www.mdpi.com/1999-4923/14/6/1220/html
Back to TopTop